$PRPO
Precipio Inc
PRICE
$1.08 -
Extented Hours
VOLUME
36,509
DAY RANGE
1.0428 - 1.1
52 WEEK
0.91 - 5.3
Join Discuss about PRPO with like-minded investors
@maletone #StockTraders.NET
main trades were $UONEK and covers and small adds on $prpo
103 Replies 7 👍 14 🔥
@Math #StockTraders.NET
$ENVB $METX $PRPO were my main focus coming into today
128 Replies 12 👍 10 🔥
@maletone #StockTraders.NET
hopefully $SPCE higher and maybe a failed Red to green move on $PRPO to re-add some covers
143 Replies 11 👍 11 🔥
Key Metrics
Market Cap
23.62 M
Beta
1.48
Avg. Volume
473.29 K
Shares Outstanding
22.71 M
Yield
0%
Public Float
0
Next Earnings Date
2022-08-11
Next Dividend Date
Company Information
Precipio has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide, as well as proprietary products that serve laboratories worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment such as the Yale School of Medicine, Harvard's Dana-Farber Cancer Institute, and the University of Pennsylvania, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care.
CEO: Paul Kinnon
Website: www.precipiodx.com
HQ: 12325 Emmet St Omaha, 68164-4243 Nebraska
Related News